Ikarian Capital, LLC Vericel Corp Transaction History
Ikarian Capital, LLC
- $328 Million
- Q2 2025
A detailed history of Ikarian Capital, LLC transactions in Vericel Corp stock. As of the latest transaction made, Ikarian Capital, LLC holds 7,900 shares of VCEL stock, worth $265,361. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,900Holding current value
$265,361% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VCEL
# of Institutions
294Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$271 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$120 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$94.5 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$82.8 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$81.8 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.58B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...